Skip to content

Clinical trials

Phase 2 Myeloproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Country / region: United States Clear all

184 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20018
20028
20035
200410
20059
200611
20078
20085
20091
20104
20118
20126
20134
20143
20157
20163
20179
20188
20195
20205
20217
20224
20236
20244
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed114
Terminated31
Recruiting18
Active, not recruiting11
Withdrawn4
Not yet recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center23
Memorial Sloan Kettering Cancer Center12
City of Hope Medical Center11
Case Comprehensive Cancer Center10
Incyte Corporation10
National Cancer Institute (NCI)10
M.D. Anderson Cancer Center7
H. Lee Moffitt Cancer Center and Research Institute6
Masonic Cancer Center, University of Minnesota6
Roswell Park Cancer Institute5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders184
Myelodysplastic Syndromes118
Leukemia, Myeloid, Acute94
Leukemia77
Precursor Cell Lymphoblastic Leukemia-Lymphoma76
Primary Myelofibrosis70
Leukemia, Lymphocytic, Chronic, B-Cell68
Leukemia, Myelomonocytic, Chronic66
Lymphoma, Non-Hodgkin61
Hodgkin Disease59

Trials

Showing 1 to 25 of 184. Each trial links to its page on Pharma Observatory.

84 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.